首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: A multidrug hypersensitivity marker?
【24h】

HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: A multidrug hypersensitivity marker?

机译:HLA-A * 31:01和甲氨蝶呤诱导的日本类风湿性关节炎患者间质性肺疾病:多药超敏标记?

获取原文
获取原文并翻译 | 示例
       

摘要

Methotrexate-induced interstitial lung disease (MI-ILD) can occur in rheumatoid arthritis (RA) patients. It is believed that Japanese RA patients are more susceptible to MI-ILD than other ethnic groups, suggesting that genetic factors are involved in the pathogenesis of MI-ILD. To date, biomarkers to predict development of MI-ILD in RA have not been established. A striking association between human leukocyte antigen (HLA) class I and cutaneous adverse reactions has been reported for several drugs. Here, we investigated HLA class I associations with MI-ILD in Japanese RA patients.
机译:甲氨蝶呤诱发的间质性肺病(MI-ILD)可能发生在类风湿关节炎(RA)患者中。据认为,日本RA患者比其他种族更易患MI-ILD,这表明遗传因素与MI-ILD的发病有关。迄今为止,尚未建立用于预测RA中MI-ILD发展的生物标记。对于几种药物,已经报道了I类人白细胞抗原(HLA)与皮肤不良反应之间的惊人联系。在这里,我们调查了日本RA患者的HLA I类与MI-ILD的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号